These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 7739942
1. Therapeutic equivalence of a generic slow-release theophylline tablet. Hendeles L, Breton AL, Beaty R, Harman E. Pharmacotherapy; 1995; 15(1):26-35. PubMed ID: 7739942 [Abstract] [Full Text] [Related]
2. Bioequivalence of a generic slow-release theophylline tablet in children. Kanthawatana S, Ahrens RC, McCubbin M, Bronsky E, Blake K, Hendeles L. J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375 [Abstract] [Full Text] [Related]
11. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children]. Iwasaki E, Baba M. Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433 [Abstract] [Full Text] [Related]
12. Single dose study of the bioequivalence of two sustained-release theophylline formulations. Contreras J, Pérez N, González R, Ontivero E, López M. Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683 [Abstract] [Full Text] [Related]
13. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur). Oosterhuis B, Brannan MD, Groen H, Peeters PA, Hempenius J, Radwanski E, Nomeir AA, Affrime MB, Jonkman JH. Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380 [Abstract] [Full Text] [Related]
15. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma. Trautlein JJ, Demers L, Esler V, Field E. Clin Ther; 1981 Aug; 4(4):252-62. PubMed ID: 7332913 [Abstract] [Full Text] [Related]